Hyaluronic Acid, Sodium Hyaluronate, Hyaluronan, HA

Hyaluronic Acid, Sodium Hyaluronate, Hyaluronan, HA
Product Description

Enzymit’s hyaluronic acid (HA) is produced in a fully cell-free enzymatic process driven by our proprietary, AI-designed enzymes. This technology delivers pharmaceutical- and cosmetic-grade HA with ≤ 0.05 EU mg⁻¹ endotoxin and ≥ 99 % assay while allowing any target molecular weight from 20 kDa to 4 MDa on the same production line—no strain changes or multi-reactor campaigns.

Key advantages

Custom molecular weight on demand – low, medium, or ultra-high (injectable) MW from one validated process.

Tight polydispersity – narrow MW distribution ensures predictable rheology and bio-performance.

Animal-free & GMO-free – pure, vegan, halal, and kosher compliant.

GMP-ready quality – produced under ISO 9001 with full traceability; DMF/eCTD pack available.

Flexible formats – supplied as lyophilised “fluff” or sterile concentrate; bespoke packaging on request.


Enzymit

  • Country/Region:
    Israel
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Specifications
  • CAS Registry Number
    9004-61-9
  • Details
    Specifications – ≥ 99 % assay (dry), ≤ 0.05 EU mg⁻¹ endotoxin, protein ≤ 0.01 %, heavy metals ≤ 1 ppm. Tight PDI, animal-free, GMO-free, ISO 9001. Formats: lyophilised powder or sterile concentrate, GMP-ready documentation (DMF/eCTD). Applications – dermal fillers, viscosupplementation (orthopaedics), ophthalmic gels, wound-care dressings, topical/cosmetic hydration, controlled-release drug delivery.
  • Selling Points
    Bone & Joint Health; Green Product; Sustainability; Enzymit supplies Hayluronic acid that has precise control over molecular weight, unparalleled monodispersity,  extremely high purity and batch to batch consistency. The process is also highly environmentally sustainable having nearly zero CO2 emissions and no alcohol used in the precipitation. Enzymit's cell-free manufacturing process reduces much of the complexity, time and costs traditionally associated with HA production. We can supply molecular weights of 10k Da up to more than 4 mio Da.
    Enzymit as been recognized as a Technology Pioneer 2024 by the World Economic Forum
  • Model
    LMW 20–200 kDa │ • MMW 200–1000 kDa │ • HMW 1–4 MDa (customisable)

Enzymit

  • Country/Region:
    Israel
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical

Enzymit resources (1)